Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Topigen Pharmaceuticals raises $24.1mm in venture round

Executive Summary

Topigen Pharmaceuticals (respiratory disease therapeutics) has raised $19mm ($Cdn22.6mm) with its second round. New investors Desjardins Venture Capital and Business Development Bank of Canada joined returning backers Fonds de Solidarite FTQ, Innovatech Montreal, and the limited partnership Societe en Commandite.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Antisense, Oligonucleotides
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies